| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | +941.8% |
| R&D Expense | $21.8M | +60.8% |
| SG&A Expense | $10.4M | +37.0% |
| Operating Income | -$29.7M | -41.8% |
| Net Income | -$29.0M | -44.9% |
| EPS (Basic) | -$1.18 | -35.6% |
| EPS (Diluted) | -$1.18 | -35.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.6M | -72.5% |
| Short-term Investments | $31.8M | — |
| Current Assets | $42.9M | +17.7% |
| Total Assets | $50.1M | +21.2% |
| Current Liabilities | $23.6M | +470.6% |
| Total Liabilities | $38.3M | +284.5% |
| Stockholders' Equity | $11.8M | -62.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.9M | +129.2% |
| Capital Expenditures | $2.0M | +67.2% |
| Investing Cash Flow | -$35.1M | -2831.8% |
| Financing Cash Flow | $4.9M | -75.9% |
| Free Cash Flow | $2.9M | +116.2% |